Announcements
Rowan Hillson Inpatient Safety Award 2022
Professor Ketan Dhatariya
Due to the pressure on hospital teams during the COVID pandemic, we postponed the 2021 competition but are now launching a revamped award for 2022 which has been amended to take into account the…
Diabetes & Endocrinology Workforce Census 2022
Dr. Stella George
We have now launched the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London…
NCEPOD Transition study - young person and parent carer online survey
Dr. Susannah Rowles
NCEPOD are undertaking a study to look at the process of transition from child to adult health services. As part of this study, they are collecting the views of young people and parent carers…
ABCD publishes the results of the Integrated survey about diabetes services
Dr. Dinesh Nagi
Today, 17th December 2021, ABCD publishes the results of the Integrated survey about diabetes services. https://bjd-abcd.com/index.php/bjd/article/view/781 Please find the link to the raw data of…
Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
Dr. Hermione Price
As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is…
The YDEF Marjorie Prize
Dr. Thomas Crabtree
The Young Diabetologist and Endocrinologist Forum committee are very pleased to be able to announce the Marjorie Prize. A little known hero in the discovery of insulin was Marjorie the dog who was…
JBDS enteral feeding forms review - we need your help
Professor Ketan Dhatariya
We are contacting you on behalf of the Joint British Diabetes Societies (JBDS) for inpatient care group. We are currently undertaking a review of our guideline "Glycaemic management during…
Withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes
Dr. Susannah Rowles
ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes . Apologies if you've had this update from multiple sources. We…
JBDS needs your help
Professor Ketan Dhatariya
JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help. We need to collect evidence and are asking UK diabetes…
Sanofi Inspired Diabetes Symposium
Professor Mike Baxter
Join us at the Sanofi Inspired Diabetes Update webinar. An opportunity for a multidisciplinary approach to inform and empower you with knowledge from a diverse range of subjects, impacting on…
Simplifying Insulin Regimens: When, Why, and How to Initiate and Intensify Insulin in Type 2 Diabetes
Dr. Dipesh Patel
Wednesday October 20th 2021, 17:00 – 18:00 BST Panelists David Strain, MBChB MD FRCP (moderator) Roopa Mehta, MBBS, MRCP Dipesh Patel, BSc, MBBS PhD, MRCP Rene Wong, MD, FRCPC, MEd…
COncise adVice on Inpatient Diabetes (COVID:Diabetes)
Professor Gerry Rayman
Post COVID-19 diebetes discharge pathway - risk stratification and follow up guidance for people being discharged from secondary care after COVID-19 infection
Dr. Christopher Walton, Consultant in Diabetes,
On Wednesday April 17th 2024 on the first day of the Diabetes UK professional meeting at the ExCel London, the British Journal of Diabetes is publishing 6 papers, online-first, detailing the findings…
